We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Venture Life Group Plc | LSE:VLG | London | Ordinary Share | GB00BFPM8908 | ORD 0.3P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 40.50 | 40.00 | 41.00 | 40.50 | 40.50 | 40.50 | 44,613 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Misc Retail Stores, Nec | 43.98M | 520k | 0.0041 | 98.78 | 50.96M |
Date | Subject | Author | Discuss |
---|---|---|---|
28/1/2017 10:03 | My fear with CLLN Red is a project mess up...similar to issues sector peers have previously reported. I sincerely hope not though. It is a feeling I can't shake... | haywards26 | |
28/1/2017 09:47 | My last two trades are under water. SSE - will come good in the near future. Clln - something has got a hold on it and is wringing the share price to death. Are the shorty pants right after all? red | redartbmud | |
28/1/2017 07:54 | QTX favourite for increasing next week. FY late Feb. Potential significant increase in income. apad | apad | |
27/1/2017 22:14 | That's very positive PJ - I reckon 2+2 for PEL = 3 !! | janeann | |
27/1/2017 15:58 | 7m trade reported @4.1p (£287k) on one of my picks PEL. Impressive NED appointment last week form Merlin Entertainments. Cant help thinking he's maybe bought in...........? Then again 2+2=5 | pj 1 | |
27/1/2017 14:53 | No such luck, red. Bipolar population. Duke of York back on the block. Produces very nice historical graphical records. Worth a look. hxxp://www.david-wil apad | apad | |
27/1/2017 10:34 | Looks below many's radar screens IMO, but continuing to deliver IMO so value will out in the end as they say...gla | qs99 | |
27/1/2017 10:03 | APAD High end on the little rock, with all of the millionaires there? Top of the range discards. red | redartbmud | |
27/1/2017 09:59 | @PJ1 thanks for the IMM tip. I listened to the podcast and I've dipped my toe in. With the results of previous trials and the update on the latest it sounds like a bit less than a complete punt :) | homebrewruss | |
27/1/2017 08:20 | RSW climbing back :-) IC today link AI and PRSM to reach a "hold" conclusion. Cheap journalism - glad I don't pay for the dreadful rag. I remember it being worth reading once, but I suspect it was because there wasn't the Web to hi-lite its shortcomings. Off on a jaunt around the charity shops this morning. apad | apad | |
27/1/2017 00:08 | Venture Life Group plc (VLG) stock had its “buy” rating restated by equities researchers at Panmure Gordon in a note issued to investors on Thursday 26 January 2017. They currently have a 128p price target on the stock. Panmure Gordon’s price objective would suggest a potential upside of 148.5% from the stock’s previous close. VLG traded up 12.33% on Thursday, hitting 57.8p. 151,322 shares of the stock were traded. The firm’s 50-day moving average price is 52.35p and its 200-day moving average price is 53.5p. The stock’s market cap is £21.3m. VLG has a 12-month low of 43p and a 12-month high of 78p. | masurenguy | |
26/1/2017 22:23 | tlatsatt Rum and honey is the mess issue in these circumstances. I will follow the order of the day. It isn't a tough one. Tomorrow is another day. - Now wasn't that the closing line of a famous film? Looks like APAD has addressed his insomnia. red | redartbmud | |
26/1/2017 21:19 | Google...VCT... venture capital trust... cool. Hope your cough goes soon mate. Plenty of vitimin C plus warm honey and lemon drink works well. All the best | thelongandtheshortandthetall | |
26/1/2017 20:44 | tlatsatt It has got worse. I now have an awful cough and cold. I have finalized my Tax Return although I have not yet submitted it. I now know how to calculate 2016/17 accurately and how to operate a VCT. I might submit it tomorrow, as long as I can stop coughing long enough. The sun set on Rsw for now. Hey Ho. red | redartbmud | |
26/1/2017 19:35 | IMM My pharma pick we discussed a few days ago put out a good update yesterday. Slightly concerned they decided to present on VOX markets so wonder if a pumping pre- placing is in the offing. Basically no nasty side effects from the P3 trial so far. Results of Trial Q1 2018. Probably goes bust then. But you just never know........As Sweet used to sing....? | pj 1 | |
26/1/2017 18:34 | I have not read the latest PG note - I found out about it from HL - but it is available via research-tree if you sign up. By the way Charles Schwab has a write up recently suggesting fair value of 142p. Long way to go...GLA | lanzarote666 | |
26/1/2017 18:12 | Lanzarote666 - do you have a link that you can post to the PG note? | masurenguy | |
26/1/2017 17:32 | Dentist, blood and tax return..... gotta be worst day ever Red! | thelongandtheshortandthetall | |
26/1/2017 17:03 | MXCT, mod? Had a quick look and it screams snake oil to me! FWIW apad | apad | |
26/1/2017 16:53 | Doesn't make money apad, so not risking much but you may like the stock, it may remind you of our favourite ABC | modform | |
26/1/2017 16:46 | Up 11% today and Panmure Gordon reiterates its buy recommendation and 128p price target. Still very quiet around here - how did the presentation go adunphy02? | lanzarote666 | |
26/1/2017 16:29 | We wuz rite, red. Piddling amounts though, mod. apad | apad | |
26/1/2017 16:28 | As the sun sinks slowly in the west, so does the Rsw share price. Hey Ho. red | redartbmud | |
26/1/2017 14:30 | thanks and agree | qs99 | |
26/1/2017 14:25 | Apad, there seems to be another buyer in FARN, so you did have some influence as it has lifted the share price up again.My very small holding in MXCT at 93p is showing some sign of life, it may never make any money but it's a pure gamble in the cell modification technology, only 1% of PF | modform |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions